AC
TAK icon

Arjuna Capital’s Takeda Pharmaceutical TAK Stock Holding History

Arjuna Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Sell
22,577
-39,618
-64% -$656K 0.08% 98
2026
Q1 		$1.15M Buy
62,195
+1,198
+2% +$21K 0.29% 80
2025
Q4 		$951K Buy
60,997
+1,191
+2% +$17K 0.23% 86
2025
Q3 		$876K Buy
59,806
+4,584
+8% +$68.1K 0.22% 85
2025
Q2 		$854K Buy
+55,222
New +$816K 0.23% 85

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Arjuna Capital's TAK Position: Q2 2026 in Review

Arjuna Capital reduced its Takeda Pharmaceutical (TAK) stake by 64% in Q2 2026, selling an estimated $656K and leaving 22,577 shares worth $362K. The position accounts for 0.08% of the portfolio, ranked #98.

Arjuna Capital first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.15M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Arjuna Capital held 22,577 shares of Takeda Pharmaceutical worth $362K as of Q2 2026.
  • Arjuna Capital sold 39,618 Takeda Pharmaceutical shares in Q2 2026, an estimated $656K.
  • Takeda Pharmaceutical made up 0.08% of Arjuna Capital's portfolio in Q2 2026, its #98 holding.
  • Arjuna Capital first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Arjuna Capital's Takeda Pharmaceutical position peaked at $1.15M in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Arjuna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.